Osteosarcopenic Visceral Obesity and Osteosarcopenic Subcutaneous Obesity, Two New Phenotypes of Sarcopenia: Prevalence, Metabolic Profile, and Risk Factors

Table 3

Association between VAT and SAT with other outcomes in osteosarcopenic obesity cohort.

Variables	Visceral adipose tissue (r)	Subcutaneous adipose tissue (r)
WBC K/µL (4.00–10.00)	0.108 ()	0.051 ()
RBC M/µL (4.00–5.00)	0.087 ()	0.051 ()
Hb g/dl (12.0–16.0)	0.063 ()	0.003 ()
Hct % (36.0–46.0)	0.019 ()	0.020 ()
MCV fL (81.0–93.0)	−0.723 ()	−0.102 ()
PLT K/µL (140–450)	−0.155 ()	0.296 ( )
Lymph  K/µL (0.80–3.60)	−0.115 ()	0.313 ()
Iron mcg/dl (45–145)	−0.058 ()	0.184 ()
Trg mmol/L (<200)	−0.155 ()	0.219 ()
Total Chol mmol/L (<200)	−0.236 ()	0.238 ()
Alb g/dl (4.02–4.76)	0.055 ()	0.699 ()
Creat mg/dl (0.57–1.11)	0.185 ()	−0.299 ( )
Azotemia mg/dl (14–40)	0.190 ()	−0.237 ()
Na mmol/l (136–145)	−0.182 ()	0.186 ()
K mmol/l (3.6–5.5)	−0.574 ()	0.960 ( )
Cl mmol/l (98–112)	0.087 ()	0.126 ()
Ca mmol/l (8.4–10.2)	−0.210 ()	−0.022 ()
Uric acid mg/dl (2.6–6.0)	−0.042 ()	−0.048 ()
Bilirub mg/dl (0.30–1.20)	0.328 ( )	−0.108 ()
AST I.U./l (7–35)	0.076 ()	−0.170 ()
ALT I.U./l (7–55)	0.340 ( )	−0.130 ()
gGT U/l (5–35)	−0.056 ()	0.124 ()
GLIC mg/dl (70–110)	0.049 (0 = 0.730)	0.101 ()
ESR mm/h (<15)	−0.053 ()	−0.031 ()
CRP mg/dl (<0.50)	0.047 ()	−0.050 ()
Folic acid ng/mL (4.6–18.7)	0.128 ()	0.032 ()
Vit B12 pg/mL (197–771)	0.001 ()	−0.065 ()
Homoc micromol/l (5–12)	−0.098 ()	−0.150 ()
BMI kg/m^2 (18.5–24.9)	0.593 ( )	0.387 ( )
FRAX anca %	0.316 ( )	0.050 ()
Handgrip strength dx	0.335 ()	−0.079 ()
TBW % (56–60)	−0.180 ()	−0.185 ()
ECW % (42–50)	−0.274 ()	0.219 ()
ICW % (50–58)	−0.042 ()	0.031 ()

NS: not statistically significant.